Translumina

Translumina is a privately held, commercial-stage medical device company specializing in interventional cardiology products. With a global manufacturing footprint and a portfolio centered on drug-eluting stents and balloons, the company has established a significant presence, particularly in India and other emerging markets. Its strategy combines in-house R&D with strategic acquisitions, such as Blue Medical Devices, to expand its technology portfolio and geographic reach. The company is positioned in the large and growing cardiovascular devices market, competing on quality, innovation, and cost-effectiveness.

Platform for designing and manufacturing interventional cardiovascular devices, including drug-eluting stents (DES) and drug-eluting balloons (DEB), with integrated R&D, regulatory, and clinical quality capabilities.

Operates in a highly competitive market dominated by multinational corporations like Abbott, Medtronic, and Boston Scientific. In its core Indian market, it competes with other domestic manufacturers and multinationals, differentiating itself on quality, cost, and local manufacturing expertise.